Teraplast Statistics

Total Valuation

Teraplast has a market cap or net worth of RON 1.08 billion. The enterprise value is 1.34 billion.

Market Cap	1.08B
Enterprise Value	1.34B

Important Dates

The next estimated earnings date is Friday, January 31, 2025.

Earnings Date	Jan 31, 2025
Ex-Dividend Date	n/a

Share Statistics

Teraplast has 2.40 billion shares outstanding. The number of shares has increased by 10.20% in one year.

Current Share Class	n/a
Shares Outstanding	2.40B
Shares Change (YoY)	+10.20%
Shares Change (QoQ)	+10.20%
Owned by Insiders (%)	42.61%
Owned by Institutions (%)	14.15%
Float	1.16B

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	1.29
PB Ratio	2.68
P/TBV Ratio	2.83
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 27.93, with an EV/FCF ratio of -17.63.

EV / Earnings	-101.04
EV / Sales	1.60
EV / EBITDA	27.93
EV / EBIT	292.75
EV / FCF	-17.63

Financial Position

The company has a current ratio of 1.47, with a Debt / Equity ratio of 0.67.

Current Ratio	1.47
Quick Ratio	0.84
Debt / Equity	0.67
Debt / EBITDA	5.74
Debt / FCF	-3.63
Interest Coverage	0.27

Financial Efficiency

Return on equity (ROE) is -3.49% and return on invested capital (ROIC) is 0.47%.

Return on Equity (ROE)	-3.49%
Return on Assets (ROA)	0.34%
Return on Capital (ROIC)	0.47%
Revenue Per Employee	872,620
Profits Per Employee	-13,817
Employee Count	959
Asset Turnover	0.99
Inventory Turnover	3.61

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -16.96% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-16.96%
50-Day Moving Average	0.45
200-Day Moving Average	0.51
Relative Strength Index (RSI)	54.82
Average Volume (20 Days)	1,112,556

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Teraplast had revenue of RON 836.84 million and -13.25 million in losses. Loss per share was -0.01.

Revenue	836.84M
Gross Profit	292.83M
Operating Income	4.57M
Pretax Income	-8.56M
Net Income	-13.25M
EBITDA	42.68M
EBIT	4.57M
Loss Per Share	-0.01

Full Income Statement

Balance Sheet

The company has 19.75 million in cash and 275.30 million in debt, giving a net cash position of -255.55 million or -0.11 per share.

Cash & Cash Equivalents	19.75M
Total Debt	275.30M
Net Cash	-255.55M
Net Cash Per Share	-0.11
Equity (Book Value)	408.09M
Book Value Per Share	0.17
Working Capital	143.33M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -23.64 million and capital expenditures -52.30 million, giving a free cash flow of -75.93 million.

Operating Cash Flow	-23.64M
Capital Expenditures	-52.30M
Free Cash Flow	-75.93M
FCF Per Share	-0.03

Full Cash Flow Statement

Margins

Gross margin is 34.99%, with operating and profit margins of 0.55% and -1.58%.

Gross Margin	34.99%
Operating Margin	0.55%
Pretax Margin	-1.02%
Profit Margin	-1.58%
EBITDA Margin	5.10%
EBIT Margin	0.55%
FCF Margin	n/a

Dividends & Yields

Teraplast does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-10.20%
Shareholder Yield	-10.20%
Earnings Yield	-1.23%
FCF Yield	-7.04%

Dividend Details

Stock Splits

The last stock split was on September 28, 2021. It was a forward split with a ratio of 1.25.

Last Split Date	Sep 28, 2021
Split Type	Forward
Split Ratio	1.25

Scores

Teraplast has an Altman Z-Score of 2.44. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.44
Piotroski F-Score	n/a